Possible effect of abatacept on the progression of interstitial lung disease in rheumatoid arthritis patients.


Rheumatoid arthritis (RA) is a generally progressive, systemic autoimmune condition characterized by chronic erosive synovitis. Interstitial lung disease (ILD) is a common extraarticular manifestation of RA and is substantially more likely to cause morbidity and mortality [1]. Several diseasemodifying anti-rheumatic drugs and numerous biological therapies… (More)
DOI: 10.1016/j.resinv.2016.03.001


2 Figures and Tables

Slides referencing similar topics